Molecular Formula | C17H17ClN2O |
Molar Mass | 300.78 |
Density | 1.1716 (rough estimate) |
Melting Point | 90-92℃ |
Boling Point | 421.2±55.0 °C(Predicted) |
Vapor Presure | 0-1Pa at 20-25℃ |
Appearance | Solid:particulate/powder |
pKa | 4.89±0.40(Predicted) |
Storage Condition | -20℃ |
Refractive Index | 1.5800 (estimate) |
In vitro study | Etifoxine (EFX), at concentrations ranging from 10 to 300 μM (higher concentrations limited its solubility), produces a dose-dependent increase in the [3H]muscimol binding at equilibrium, to 155±2% of its control value at 300 μM EFX. |
Toxicity | LD50 orally in mice: 12 g/kg (Hoffmann) |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.325 ml | 16.623 ml | 33.247 ml |
5 mM | 0.665 ml | 3.325 ml | 6.649 ml |
10 mM | 0.332 ml | 1.662 ml | 3.325 ml |
5 mM | 0.066 ml | 0.332 ml | 0.665 ml |